Aquestive Therapeutics (AQST) Receivables - Other (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Receivables - Other of $1.6 million for Q1 2026, down 27.47% year-over-year from $2.2 million in Q1 2025, and down 83.54% quarter-over-quarter from $9.8 million in Q4 2025.
Aquestive Therapeutics (AQST) Receivables - Other (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Receivables - Other history runs 10 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 27.47% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 27.47% YoY), while the FY2025 annual figure was $9.8 million, up 294.26% from the prior year.
- Receivables - Other for Q1 2026 stood at $1.6 million, down from $9.8 million in the prior quarter.
- The five-year high for Receivables - Other was $9.8 million in Q4 2025, with the low at $1.6 million in Q1 2026.
- The 5-year median for Receivables - Other is $2.2 million (2023), against an average of $2.7 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other tumbled 53.38% in 2024, then soared 294.26% in 2025.
- Aquestive Therapeutics' Receivables - Other stood at $2.1 million in 2022, then jumped by 36.28% to $2.9 million in 2023, then dropped by 15.16% to $2.5 million in 2024, then jumped by 294.26% to $9.8 million in 2025, then tumbled by 83.54% to $1.6 million in 2026.
- Business Quant data shows AQST's Receivables - Other at $1.6 million in Q1 2026, $9.8 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Mn |
| Jun 30, 2026 | 1.61 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Mar 31, 2026 | 1.61 Mn |
| Dec 31, 2025 | 9.75 Mn |
| Dec 31, 2025 | 9.75 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.64 Mn |